<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Medicis Pharmaceutical from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Medicis Pharmaceutical news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 07:04:43 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Medicis+Pharmaceutical" rel="self" type="application/rss+xml" />

	
<item><title>Form 4 MEDICIS PHARMACEUTICAL For: Feb 07 Filed by: PRYGOCKI MARK A SR</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037396&amp;HITNO=0&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037396&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537055013%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037396&amp;HITNO=0&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037396&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537055013%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Form 4 MEDICIS PHARMACEUTICAL For: Feb 07 Filed by: WORTZMAN MITCHELL S</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037394&amp;HITNO=1&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037394&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537054351%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037394&amp;HITNO=1&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037394&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537054351%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Form 4 MEDICIS PHARMACEUTICAL For: Feb 07 Filed by: Cooper Joseph Patrick</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037323&amp;HITNO=2&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037323&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537027525%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037323&amp;HITNO=2&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037323&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537027525%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Form 4 MEDICIS PHARMACEUTICAL For: Feb 07 Filed by: IPPOLITO VINCENT P</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037322&amp;HITNO=3&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037322&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537027566%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037322&amp;HITNO=3&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037322&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537027566%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Form 4 MEDICIS PHARMACEUTICAL For: Feb 07 Filed by: PETERSON RICHARD D</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037319&amp;HITNO=4&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037319&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537027342%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037319&amp;HITNO=4&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037319&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537027342%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Glenmark Pharmaceuticals - Steady growth recovery</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027828&amp;HITNO=5&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027828&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532388176%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027828&amp;HITNO=5&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027828&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532388176%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Equity Bulls:</description></item>
<item><title>Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma and Johnson &amp; Johnson</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025271&amp;HITNO=6&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025271&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529596524%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025271&amp;HITNO=6&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025271&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529596524%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma a</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024945&amp;HITNO=7&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024945&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529278648%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024945&amp;HITNO=7&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024945&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529278648%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>Medicis Pharmaceutical: The Trend Continues Lower (MRX)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022815&amp;HITNO=8&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022815&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527870886%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022815&amp;HITNO=8&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022815&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527870886%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Medicis Pharmaceutical: The Trend Continues Lower (MRX)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022651&amp;HITNO=9&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022651&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527776884%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022651&amp;HITNO=9&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022651&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527776884%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Medicis wins FDA approval for Restylane and Perlane with lidocaine</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018666&amp;HITNO=10&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018666&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525869520%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018666&amp;HITNO=10&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018666&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525869520%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma and Johnson &amp; Johnson</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023563&amp;HITNO=11&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023563&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528256618%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023563&amp;HITNO=11&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023563&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528256618%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma and Johnson &amp; Johnson</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023648&amp;HITNO=12&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023648&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528298634%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023648&amp;HITNO=12&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023648&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528298634%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma a</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023539&amp;HITNO=13&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023539&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528245393%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023539&amp;HITNO=13&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023539&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528245393%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Globe Investor:</description></item>
<item><title>Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma a</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023499&amp;HITNO=14&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023499&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528232217%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023499&amp;HITNO=14&amp;MSIZE=73&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Medicis%20Pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023499&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528232217%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire UK:</description></item>
</channel></rss>